Skip to main content
. Author manuscript; available in PMC: 2019 Jul 26.
Published in final edited form as: Value Health. 2018 Apr 9;21(6):724–731. doi: 10.1016/j.jval.2018.02.002

Fig. 1 –

Fig. 1 –

Comparisons of cumulative complications avoided and cost reductions vs. the Baxter et al. [13] study. Each scatterplot denotes a comparison of results from the modeling groups and those from the Baxter study. The dotted line is the fitted regression line of all comparisons, and the solid line denotes hypothetical perfect agreement between values generated from the modeling groups and those from the original study, that is, R2 = 1 and line intersecting the origin (0). Overall, there is a reasonable good agreement between the results from the modeling groups and those from the Baxter study. The slopes of the regression line are 0.66 and 0.71 and the R2 are 0.35 and 0.52 for the comparisons of complications avoided and cost reductions, respectively. ECHO, Economics and Health Outcomes Model of T2DM; MDM-TTM, Medical Decision Modeling Inc. —Treatment Transitions Model; IQVIA-CDM, IQVIA-Core Diabetes Model; T2DM, type 2 diabetes mellitus.